-
Microbiological monitoring of chronic viral hepatitisSeme, Katja, 1966- ...Close virological monitoring of patients with chronic hepatitis B and C is important for the determination of disease stage and progression, for assessing the need for treatment and for monitoring ... the antiviral therapy response. Virological tests for monitoring chronic infection with hepatitis B virus (HBV) include serological tests, nucleic acid techniques for the detection of HBV DNA, tests for the determination of resistance of HBV to antiviral agents, tests for the determination of HBV genotype, and tests for the determination of different mutations in HBV genome. HBV DNA viral load tests are the most important tools for the management of patients with chronichepatitis B. They are used for the management of anti-HBe positive patients (distinction of the inactive HBsAg carriers from the patients with chronic HBeAg-negative hepatitis), for the decision to treat and selection of optimal antiviral therapy, and for monitoring the effectiveness of HBV antiviral treatment. Virological tests for monitoring chronic hepatitis C virus (HCV) infection include qualitative and quantitative nucleic acid techniques for the detection of HCV RNA, test for the quantitative determination of HCV core antigen, and methods for the determination of HCV genotype. The patients with chronic hepatitis C that are not considered for antiviral therapy should be followed up mainly using non-microbiological methods. When antiviral combination therapy with pegylated interferon-alpha and ribavirin is considered in chronic hepatitis C patients, the HCV genotype has to be determined first, as it determines the duration of treatment and thedose of ribavirin. During the antiviral therapy, it is recommended to determine the end of treatment response and the sustained viral response in all treated patients. Additionally, in the patients infected with HCV genotype1 or 4, the early viral response should be determined. (Abstract truncated at 2000 characters).Vir: Viral hepatitis : proceedings (Str. 158-173)Vrsta gradiva - prispevek na konferenciLeto - 2004Jezik - angleškiCOBISS.SI-ID - 18617817
Avtor
Seme, Katja, 1966- |
Poljak, Mario, 1965- |
Meško Meglič, Karmen |
Fujs Komloš, Kristina |
Babič, Dunja |
Štamol, Tina
Teme
Hepatitis, Viral, Human |
Hepatitis, Chronic Active |
Hepatitis B |
Virology |
Diagnosis |
Therapy |
Hepatitis B E Antigens |
Hepatitis B Surface Antigens |
Dna, Viral |
Antiviral Agents |
Drug Resistance, Microbial |
Genotype |
Hepatitis C |
Virology |
Therapy |
Rna, Viral |
Hepatitis B |
Hepatitis B e, antigeni |
Hepatitis B, površinski antigeni |
Hepatitis virusni, človeški |
Antivirusna zdravila |
DNA virusna |
Genotip |
Hepatitis C |
RNA virusna |
Zdravilo, rezistenca mikrobna
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Seme, Katja, 1966- | 14504 |
Poljak, Mario, 1965- | 11622 |
Meško Meglič, Karmen | 24280 |
Fujs Komloš, Kristina | 25986 |
Babič, Dunja | 22461 |
Štamol, Tina | 25988 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.